作者：
Francesco,Di Meo [1]
;
Anjushree,Iyer [2]
;
Keith,Akama [2]
;
Rujin,Cheng [2]
;
Christina,Yu [3]
;
Annamaria,Cesarano [1]
;
Noriyoshi,Kurihara [3]
;
Hirofumi,Tenshin [3]
;
Arafat,Aljoufi [4]
;
Silvia,Marino [3]
;
Rajesh K,Soni [5]
;
Julie,Roda [2]
;
James,Sissons [2]
;
Ly P,Vu [6]
;
Monica,Guzman [7]
;
Kun,Huang [3]
;
Tamara,Laskowski [8]
;
Hal E,Broxmeyer [4]
;
David G,Roodman [3]
;
Fabiana,Perna [9]
作者单位：
Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
[1]
NGM Biopharmaceuticals, San Francisco, CA, USA.
[2]
Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
[3]
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, USA.
[4]
Proteomics and Macromolecular Crystallography Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
[5]
British Columbia Cancer Center, Vancouver, BC, Canada.
[6]
Weill Cornell Medical College, New York, NY, USA.
[7]
Lonza Personalized Medicine, Basel, Switzerland.
[8]
Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: fabiana.perna@moffitt.org.
[9]
DOI
10.1016/j.xcrm.2023.101110
PMID
37467717
发布时间
2023-08-04
换一批
换一批
